<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33087694</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Prevention of mitochondrial impairment by inhibition of protein phosphatase 1 activity in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>888</StartPage><MedlinePgn>888</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">888</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-020-03102-8</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by progressive loss of motor neurons (MNs) and subsequent muscle weakness. These pathological features are associated with numerous cellular changes, including alteration in mitochondrial morphology and function. However, the molecular mechanisms associating mitochondrial structure with ALS pathology are poorly understood. In this study, we found that Dynamin-related protein 1 (Drp1) was dephosphorylated in several ALS models, including those with SOD1 and TDP-43 mutations, and the dephosphorylation was mediated by the pathological induction of protein phosphatase 1 (PP1) activity in these models. Suppression of the PP1-Drp1 cascade effectively prevented ALS-related symptoms, including mitochondrial fragmentation, mitochondrial complex I impairment, axonal degeneration, and cell death, in primary neuronal culture models, iPSC-derived human MNs, and zebrafish models in vivo. These results suggest that modulation of PP1-Drp1 activity may be a therapeutic target for multiple pathological features of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>So Yoen</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Korea University College of Medicine, Brain Korea 21 plus, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical school, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ju-Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Korea University College of Medicine, Brain Korea 21 plus, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Ah-Young</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Graduate School of Medicine, Korea University, Ansan, Gyeonggido, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Youhwa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Korea University College of Medicine, Brain Korea 21 plus, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Joo-Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do, 440-746, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hae-Chul</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0003-2095-3186</Identifier><AffiliationInfo><Affiliation>Graduate School of Medicine, Korea University, Ansan, Gyeonggido, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Korea University College of Medicine, Brain Korea 21 plus, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Gonzalez</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical school, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Jae Ryun</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Korea University College of Medicine, Brain Korea 21 plus, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Woong</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-1792-4894</Identifier><AffiliationInfo><Affiliation>Department of Anatomy, Korea University College of Medicine, Brain Korea 21 plus, Seoul, 02841, Republic of Korea. woongsun@korea.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D054645">Protein Phosphatase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054645" MajorTopicYN="N">Protein Phosphatase 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33087694</ArticleId><ArticleId IdType="pmc">PMC7578657</ArticleId><ArticleId IdType="doi">10.1038/s41419-020-03102-8</ArticleId><ArticleId IdType="pii">10.1038/s41419-020-03102-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:3&#x2013;22. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Song Y, Kincaid B, Bossy B, Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1&#x3b1;. Neurobiol. Dis. 2013;51:72&#x2013;81. doi: 10.1016/j.nbd.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms MB, Baloh RH. Clinical neurogenetics: amyotrophic lateral sclerosis. Neurol. Clin. 2013;31:929&#x2013;950. doi: 10.1016/j.ncl.2013.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2013.05.003</ArticleId><ArticleId IdType="pmc">PMC3815699</ArticleId><ArticleId IdType="pubmed">24176417</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Parone PA, et al. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. 2013;33:4657&#x2013;4671. doi: 10.1523/JNEUROSCI.1119-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1119-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711648</ArticleId><ArticleId IdType="pubmed">23486940</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 1997;244(Suppl 2):S3&#x2013;S14. doi: 10.1007/BF03160574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03160574</ArticleId><ArticleId IdType="pubmed">9178165</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher NR, et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin. 2015;7:409&#x2013;414. doi: 10.1016/j.nicl.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank EM, et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:2845&#x2013;16. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Faes L, Callewaert G. Mitochondrial dysfunction in familial amyotrophic lateral sclerosis. J. Bioenerg. Biomembr. 2011;43:587&#x2013;592. doi: 10.1007/s10863-011-9393-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-011-9393-0</ArticleId><ArticleId IdType="pubmed">22072073</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener. Dis. 2004;1:245&#x2013;254. doi: 10.1159/000085063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000085063</ArticleId><ArticleId IdType="pubmed">16908975</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst. Rev. 2012;330:CD001447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H. Considerations for pharmacotherapy use in patients with amyotrophic lateral sclerosis: the earlier it starts, the better the results. Expert Opin. Pharmacother. 2019;20:1671&#x2013;1674. doi: 10.1080/14656566.2019.1636965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2019.1636965</ArticleId><ArticleId IdType="pubmed">31256690</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, et al. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:610&#x2013;617. doi: 10.3109/21678421.2014.959024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959024</ArticleId><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology. 1996;47:535&#x2013;540. doi: 10.1212/WNL.47.2.535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.2.535</ArticleId><ArticleId IdType="pubmed">8757033</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G, Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion. 2005;5:77&#x2013;87. doi: 10.1016/j.mito.2005.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2005.01.002</ArticleId><ArticleId IdType="pubmed">16050975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 1996;204:53&#x2013;56. doi: 10.1016/0304-3940(96)12314-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12314-4</ArticleId><ArticleId IdType="pubmed">8929976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 1998;18:3241&#x2013;3250. doi: 10.1523/JNEUROSCI.18-09-03241.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-09-03241.1998</ArticleId><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, et al. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor. Neurons Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 1996;16:4069&#x2013;4079. doi: 10.1523/JNEUROSCI.16-13-04069.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-13-04069.1996</ArticleId><ArticleId IdType="pmc">PMC6578994</ArticleId><ArticleId IdType="pubmed">8753869</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron. 2011;71:35&#x2013;48. doi: 10.1016/j.neuron.2011.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.06.031</ArticleId><ArticleId IdType="pubmed">21745636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman II, Pedersen WA, Springer JE, Mattson MP. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 1999;160:28&#x2013;39. doi: 10.1006/exnr.1999.7190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1999.7190</ArticleId><ArticleId IdType="pubmed">10630188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereiter-Hahn J, Jendrach M. Mitochondrial dynamics. Int. Rev. Cell Mol. Biol. 2010;284:1&#x2013;65. doi: 10.1016/S1937-6448(10)84001-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1937-6448(10)84001-8</ArticleId><ArticleId IdType="pubmed">20875628</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho HM, et al. Drp1-Zip1 Interaction regulates mitochondrial quality surveillance system. Mol. Cell. 2019;73:364&#x2013;376.e8. doi: 10.1016/j.molcel.2018.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.11.009</ArticleId><ArticleId IdType="pubmed">30581142</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho B, Choi SY, Cho HM, Kim HJ, Sun W. Physiological and pathological significance of dynamin-related protein 1 (drp1)-dependent mitochondrial fission in the nervous system. Exp. Neurobiol. 2013;22:149&#x2013;157. doi: 10.5607/en.2013.22.3.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2013.22.3.149</ArticleId><ArticleId IdType="pmc">PMC3807002</ArticleId><ArticleId IdType="pubmed">24167410</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis. Curr. Neurovasc Res. 2013;10:222&#x2013;230. doi: 10.2174/15672026113109990060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672026113109990060</ArticleId><ArticleId IdType="pubmed">23713734</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens JC, et al. Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag-implications for research into amyotrophic lateral sclerosis (ALS) PLoS ONE. 2010;5:e9541. doi: 10.1371/journal.pone.0009541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009541</ArticleId><ArticleId IdType="pmc">PMC2833207</ArticleId><ArticleId IdType="pubmed">20221404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J, Park H-C, Topczewska JM, Mawdsley DJ, Appel B. Neural cell fate analysis in zebrafish using olig2 BAC transgenics. Methods Cell Sci. 2003;25:7&#x2013;14. doi: 10.1023/B:MICS.0000006847.09037.3a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:MICS.0000006847.09037.3a</ArticleId><ArticleId IdType="pubmed">14739582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H, et al. Synaptic NMDA receptor stimulation activates PP1 by inhibiting its phosphorylation by Cdk5. J. Cell Biol. 2013;203:521&#x2013;535. doi: 10.1083/jcb.201303035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201303035</ArticleId><ArticleId IdType="pmc">PMC3824016</ArticleId><ArticleId IdType="pubmed">24189275</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paepe B, De Bleecker JL, Van Coster R. Histochemical methods for the diagnosis of mitochondrial diseases. Curr. Protoc. Hum. Genet. 2009;Chapter 19:Unit19.2&#x2013;19.2.19.</Citation><ArticleIdList><ArticleId IdType="pubmed">19806589</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho B, et al. CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation. Exp. Mol. Med. 2014;46:e105&#x2013;e105. doi: 10.1038/emm.2014.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.36</ArticleId><ArticleId IdType="pmc">PMC4119210</ArticleId><ArticleId IdType="pubmed">25012575</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohadwala M, et al. Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc. Natl Acad. Sci. USA. 1994;91:6408&#x2013;6412. doi: 10.1073/pnas.91.14.6408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.14.6408</ArticleId><ArticleId IdType="pmc">PMC44211</ArticleId><ArticleId IdType="pubmed">8022797</ArticleId></ArticleIdList></Reference><Reference><Citation>Korrodi-Greg&#xf3;rio L, Esteves SLC, Fardilha M. Protein phosphatase 1 catalytic isoforms: specificity toward interacting proteins. Transl. Res. 2014;164:366&#x2013;391. doi: 10.1016/j.trsl.2014.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2014.07.001</ArticleId><ArticleId IdType="pubmed">25090308</ArticleId></ArticleIdList></Reference><Reference><Citation>Coussee E, et al. G37R SOD1 mutant alters mitochondrial complex I activity, Ca(2+) uptake and ATP production. Cell Calcium. 2011;49:217&#x2013;225. doi: 10.1016/j.ceca.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2011.02.004</ArticleId><ArticleId IdType="pubmed">21388680</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori I, et al. Differential toxicity of TAR DNA&#x2010;binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells. J. Neurochemistry. 2018;146:585&#x2013;597. doi: 10.1111/jnc.14465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14465</ArticleId><ArticleId IdType="pubmed">29779213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SA, et al. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci. Lett. 2018;678:8&#x2013;15. doi: 10.1016/j.neulet.2018.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.053</ArticleId><ArticleId IdType="pmc">PMC5975202</ArticleId><ArticleId IdType="pubmed">29715546</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012;4:145ra104&#x2013;145ra104. doi: 10.1126/scitranslmed.3004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004052</ArticleId><ArticleId IdType="pubmed">22855461</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl Acad. Sci. U. S. A. 2015;112:E6993&#x2013;E7002. doi: 10.1073/pnas.1520639112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7:253. doi: 10.3389/fncel.2013.00253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Pandey UB. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front Mol. Neurosci. 2017;10:263. doi: 10.3389/fnmol.2017.00263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00263</ArticleId><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung C, Sha D, Li L, Chin L-S. Parkin protects against misfolded SOD1 toxicity by promoting its aggresome formation and autophagic clearance. Mol. Neurobiol. 2016;53:6270&#x2013;6287. doi: 10.1007/s12035-015-9537-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9537-z</ArticleId><ArticleId IdType="pmc">PMC4866905</ArticleId><ArticleId IdType="pubmed">26563499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C-C, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott AB, Bossy-Wetzel E. Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann. N. Y. Acad. Sci. 2008;1147:283&#x2013;292. doi: 10.1196/annals.1427.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1427.030</ArticleId><ArticleId IdType="pmc">PMC2605288</ArticleId><ArticleId IdType="pubmed">19076450</ArticleId></ArticleIdList></Reference><Reference><Citation>Otera H, Mihara K. Mitochondrial dynamics: functional link with apoptosis. Int J. Cell Biol. 2012;2012:821676&#x2013;10. doi: 10.1155/2012/821676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/821676</ArticleId><ArticleId IdType="pmc">PMC3320010</ArticleId><ArticleId IdType="pubmed">22536251</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S, et al. The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling. Cell Death Dis. 2014;5:e1368&#x2013;e1368. doi: 10.1038/cddis.2014.320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.320</ArticleId><ArticleId IdType="pmc">PMC4454299</ArticleId><ArticleId IdType="pubmed">25118928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J. Biol. Chem. 2011;286:11649&#x2013;11658. doi: 10.1074/jbc.M110.144238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.144238</ArticleId><ArticleId IdType="pmc">PMC3064217</ArticleId><ArticleId IdType="pubmed">21292769</ArticleId></ArticleIdList></Reference><Reference><Citation>Manczak M, Reddy PH. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer&#x2019;s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 2012;21:2538&#x2013;2547. doi: 10.1093/hmg/dds072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds072</ArticleId><ArticleId IdType="pmc">PMC3349426</ArticleId><ArticleId IdType="pubmed">22367970</ArticleId></ArticleIdList></Reference><Reference><Citation>Otera H, Mihara K. Discovery of the membrane receptor for mitochondrial fission GTPase Drp1. Small GTPases. 2011;2:167&#x2013;172. doi: 10.4161/sgtp.2.3.16486.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/sgtp.2.3.16486</ArticleId><ArticleId IdType="pmc">PMC3136948</ArticleId><ArticleId IdType="pubmed">21776419</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppins S. The regulation of mitochondrial dynamics. Curr. Opin. Cell Biol. 2014;29:46&#x2013;52. doi: 10.1016/j.ceb.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2014.03.005</ArticleId><ArticleId IdType="pubmed">24747170</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, et al. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 2018;10:109. doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007;8:939&#x2013;944. doi: 10.1038/sj.embor.7401062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7401062</ArticleId><ArticleId IdType="pmc">PMC2002551</ArticleId><ArticleId IdType="pubmed">17721437</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, et al. Drp1-mediated mitochondrial dynamics and survival of developing chick motoneurons during the period of normal programmed cell death. FASEB J. 2013;27:51&#x2013;62. doi: 10.1096/fj.12-211920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-211920</ArticleId><ArticleId IdType="pmc">PMC3528306</ArticleId><ArticleId IdType="pubmed">22997225</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. A Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics during endocytosis. Nat. Cell Biol. 2013;15:773&#x2013;785. doi: 10.1038/ncb2791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2791</ArticleId><ArticleId IdType="pmc">PMC3725990</ArticleId><ArticleId IdType="pubmed">23792689</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy MS, Page R, Peti W. Regulation of protein phosphatase 1 by intrinsically disordered proteins. Biochem. Soc. Trans. 2012;40:969&#x2013;974. doi: 10.1042/BST20120094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20120094</ArticleId><ArticleId IdType="pmc">PMC3502941</ArticleId><ArticleId IdType="pubmed">22988849</ArticleId></ArticleIdList></Reference><Reference><Citation>Peti W, Nairn AC, Page R. Structural basis for protein phosphatase 1 regulation and specificity. FEBS J. 2013;280:596&#x2013;611. doi: 10.1111/j.1742-4658.2012.08509.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2012.08509.x</ArticleId><ArticleId IdType="pmc">PMC3350600</ArticleId><ArticleId IdType="pubmed">22284538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobbestael E, et al. Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle. Biochem. J. 2013;456:119&#x2013;128. doi: 10.1042/BJ20121772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20121772</ArticleId><ArticleId IdType="pmc">PMC5141581</ArticleId><ArticleId IdType="pubmed">23937259</ArticleId></ArticleIdList></Reference><Reference><Citation>Braithwaite SP, Stock JB, Lombroso PJ, Nairn AC. Protein phosphatases and Alzheimer&#x2019;s disease. Prog. Mol. Biol. Transl. Sci. 2012;106:343&#x2013;379. doi: 10.1016/B978-0-12-396456-4.00012-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-396456-4.00012-2</ArticleId><ArticleId IdType="pmc">PMC3739963</ArticleId><ArticleId IdType="pubmed">22340724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramser EM, et al. Amyloid-&#x3b2; oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol. Biol. Cell. 2013;24:2494&#x2013;2505. doi: 10.1091/mbc.e12-12-0858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e12-12-0858</ArticleId><ArticleId IdType="pmc">PMC3744947</ArticleId><ArticleId IdType="pubmed">23783030</ArticleId></ArticleIdList></Reference><Reference><Citation>Das I, et al. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science. 2015;348:239&#x2013;242. doi: 10.1126/science.aaa4484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa4484</ArticleId><ArticleId IdType="pmc">PMC4490275</ArticleId><ArticleId IdType="pubmed">25859045</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll J, et al. Bovine complex I is a complex of 45 different subunits. J. Biol. Chem. 2006;281:32724&#x2013;32727. doi: 10.1074/jbc.M607135200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M607135200</ArticleId><ArticleId IdType="pubmed">16950771</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;ttemann M, Lee I, Samavati L, Yu H, Doan JW. Regulation of mitochondrial oxidative phosphorylation through cell signaling. Biochim. Biophys. Acta. 2007;1773:1701&#x2013;1720. doi: 10.1016/j.bbamcr.2007.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2007.10.001</ArticleId><ArticleId IdType="pubmed">18240421</ArticleId></ArticleIdList></Reference><Reference><Citation>Remacle C, Barbieri MR, Cardol P, Hamel PP. Eukaryotic complex I: functional diversity and experimental systems to unravel the assembly process. Mol. Genet. Genomics. 2008;280:93&#x2013;110. doi: 10.1007/s00438-008-0350-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-008-0350-5</ArticleId><ArticleId IdType="pubmed">18563446</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeitink J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001;2:342&#x2013;352. doi: 10.1038/35072063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35072063</ArticleId><ArticleId IdType="pubmed">11331900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse SE, et al. Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab. 2008;7:312&#x2013;320. doi: 10.1016/j.cmet.2008.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.02.004</ArticleId><ArticleId IdType="pmc">PMC2593686</ArticleId><ArticleId IdType="pubmed">18396137</ArticleId></ArticleIdList></Reference><Reference><Citation>Petruzzella V, Papa S. Mutations in human nuclear genes encoding for subunits of mitochondrial respiratory complex I: the NDUFS4 gene. Gene. 2002;286:149&#x2013;154. doi: 10.1016/S0378-1119(01)00810-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(01)00810-1</ArticleId><ArticleId IdType="pubmed">11943471</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano G, Sardanelli AM, Signorile A, Papa S, Larsen MR. The phosphorylation pattern of bovine heart complex I subunits. Proteomics. 2007;7:1575&#x2013;1583. doi: 10.1002/pmic.200600801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200600801</ArticleId><ArticleId IdType="pubmed">17443843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocsfalvi G, et al. Phosphorylation of B14.5a subunit from bovine heart complex I identified by titanium dioxide selective enrichment and shotgun proteomics. Mol. Cell Proteom. 2007;6:231&#x2013;237. doi: 10.1074/mcp.M600268-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M600268-MCP200</ArticleId><ArticleId IdType="pubmed">17114648</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling B, et al. Mass spectrometric identification of a novel phosphorylation site in subunit NDUFA10 of bovine mitochondrial complex I. FEBS Lett. 2005;579:2485&#x2013;2490. doi: 10.1016/j.febslet.2005.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2005.03.061</ArticleId><ArticleId IdType="pubmed">15848193</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>